HER kinase activation confers resistance to MET tyrosine kinase inhibition in MET oncogene-addicted gastric cancer cells

Thomas Bachleitner‐Hofmann, Martin R. Weiser(Memorial Sloan Kettering Cancer Center)
Molecular Cancer Therapeutics
October 31, 2008
Cited by 126


Related Papers